HERE is good news for all those trying to
beat hunger pangs and stay on the
slimmer side. Scientists from the
institute of Health and Medical Sciences
(INSERM), France, are a few steps away
from developing a new diet control
therapy that involves the use of neurotransmitters, which are chemicals that
brain cells use to communicate with
each other. Researchers have been
studying an a ppetite- related neurotransmitter called CCK-8, that is usually
produced after food intake to control
the appetite of the eater. This neurotransmitter signals the eater through
the brain cells to stop eating.
Now scientists are trying to use CCK-8, also known as 'satiety molecule', as a possible appetite-suppression agent for people who should be on diet but just cannot cut down their appetite for delicious food. Researchers at INSERM identified an enzyme TPP11, which breaks, down CCK-8 in the digestive tract before it can regulate diet. They have also designed a chemical, butabindide, which would inactivate TPPII and enable CCK-8 to do its appetite-suppressing job.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.